Guardant Reveal

A blood test after surgery that checks for minimal residual disease and helps assess recurrence risk.

Vetted listingTakes insuranceFinancial aid available
Diagnostics

Consented intake · your records travel with you · nothing moves without your sign-off

Why Guardant exists

Guardant Reveal is a blood test used after cancer surgery to detect minimal residual disease and assess the risk of recurrence. It is for patients who have completed surgery and want a clearer read on whether cancer may return. That information matters because it can shape how closely a patient is monitored and what they and their care team plan for next.

Prefer the source? Guardant Reveal's own site has more.

Get started with Guardant Reveal

Coverage, insurance & cost

The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Guardant Reveal handles billing.

Insurance

Accepted

Financial aid

Available

Prior auth

Required

In-network carriers

MedicareBlue Cross Blue Shield

Common questions about Guardant

Does Guardant take insurance?

Guardant accepts insurance; In-network carriers include Medicare, Blue Cross Blue Shield; financial assistance is available. Add your plan on OpenCancer to check coverage before you commit.

How do I connect with Guardant?

Through OpenCancer's consented intake: enter your details once, choose exactly which records travel with the request, and sign a consent that covers this connection only. Nothing is shared without your sign-off.

Ask about this service

Answers grounded in Guardant's details here. Educational only; your oncologist directs treatment.

Powered by Navis on opencancer.ai

Who this is for

Cancer types served

breastcolorectallung

Generally requires prior treatment history — eligibility confirmed during intake.

Also consider

Other providers in similar categories.

Get personalized guidance for your case

This page is general information. Upload your records for analysis specific to YOUR diagnosis.